SCHEMBL27645262

SCHEMBL27645262

Cc1cc(C)c(C2CCN(c3cc4ncccc4cc3O)CC2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
EPHX2 P34913 1/20 0.36
IRAK1 P51617 3/20 0.35
IRAK4 Q9NWZ3 3/20 0.35
HTR1A P08908 1/20 0.35
MAPT P10636 3/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CHRM5 P08912 1/20 0.34
MEN1 O00255 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 1/20 0.34
GSK3B P49841 1/20 0.34
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27645259 0.85 PDGFRB (0.40) ALDH1A1EPHX2HTR1AMAPTSMN1; SMN2
SCHEMBL2091521 0.79 CHEK2 (0.42) ALDH1A1IRAK1IRAK4MEN1CASP1
SCHEMBL246244 0.71 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EGAASMN1; SMN2
SCHEMBL2090809 0.70 MTOR (0.39) EPHX2IRAK1IRAK4GAAPDE4B
SCHEMBL15275374 0.68 NCF1 (0.46) ALDH1A1IRAK4MAPTKDM4EGAA
SCHEMBL15275373 0.68 IRAK4 (0.46) ALDH1A1IRAK4MAPTKDM4EGAA
SCHEMBL5542743 0.65 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EGAASMN1; SMN2
SCHEMBL2091712 0.64 ALDH1A1 (0.40) ALDH1A1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL359830 0.64 IRAK1 (0.52) IRAK1IRAK4
SCHEMBL2091518 0.64 CXCR4 (0.43) IRAK1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed